Through a mix of account wins and continued work with such staple clients as Santen Pharmaceutical, the firm generated $13 million in revenue last year.
Eight years on, Create NYC has carved out a niche for itself, happy to serve as a complement agency or AOR once such foundational elements as core branding have been established.
The Bloc mainly handles high-science projects in the primary-care space, but has expanded its expertise to accommodate providers, genomics companies, and device companies, among others.
Top 25 autoimmune brands in 2016, based on U.S. sales
Makers of biosimilars have targeted a few of the top-selling autoimmune drugs. Get ready for some of the highest-stakes pricing and access skirmishes in recent pharma history.
Drugmakers target severe asthma patients with biologics, but payers raise pricing issue
A loaded hemophilia A drug market is an indication patients in and around it are well-served, but that hasn’t stopped contenders such as Roche’s emicizumab.
Orphan drugs face criticism on prices — and from patients